NO20065079L - Materialer og metoder for behandling av koaguleringssykdommer - Google Patents

Materialer og metoder for behandling av koaguleringssykdommer

Info

Publication number
NO20065079L
NO20065079L NO20065079A NO20065079A NO20065079L NO 20065079 L NO20065079 L NO 20065079L NO 20065079 A NO20065079 A NO 20065079A NO 20065079 A NO20065079 A NO 20065079A NO 20065079 L NO20065079 L NO 20065079L
Authority
NO
Norway
Prior art keywords
sub
compounds
methods
salts
treatment
Prior art date
Application number
NO20065079A
Other languages
English (en)
Other versions
NO338837B1 (no
Inventor
Pascal Druzgala
Cyrus Becker
Original Assignee
Aryx Therapeutics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/822,129 external-priority patent/US7145020B2/en
Application filed by Aryx Therapeutics filed Critical Aryx Therapeutics
Publication of NO20065079L publication Critical patent/NO20065079L/no
Publication of NO338837B1 publication Critical patent/NO338837B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/42—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4
    • C07D311/56—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 without hydrogen atoms in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Den aktuelle oppfinnelsen skaffer til veie antikoagulantforbindelser fra formel (I): og farmasøytisk godtatte salter derav. Forbindelsene tilknyttet til den aktuelle forbindelsen kan brukes til å behandle visse grupper mennesker som er utsatt for risiko og vil på denne måten tilby hjelp med symptomer, forbedring av livskvaliteten, og forhindre akutte og langvarige komplikasjoner, redusere dødeligheten og behandle ledsagende tilstander. Oppfinnelsen består videre av sammensetninger bestående av oppfinnelsens forbindelser og salter, i tillegg til metoder til bruk av forbindelsene, saltene, og de sammensetningene som er tilknyttet oppfinnelsen.
NO20065079A 2004-04-08 2006-11-03 Forbindelse, sammensetning og anvendelse ved behandling av koaguleringssykdommer NO338837B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56112104P 2004-04-08 2004-04-08
US10/822,129 US7145020B2 (en) 2001-04-24 2004-04-08 Materials and methods for treating coagulation disorders
PCT/US2005/012091 WO2005100336A1 (en) 2004-04-08 2005-04-08 Materials and methods for treating coagulation disorders

Publications (2)

Publication Number Publication Date
NO20065079L true NO20065079L (no) 2006-11-03
NO338837B1 NO338837B1 (no) 2016-10-24

Family

ID=34965219

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065079A NO338837B1 (no) 2004-04-08 2006-11-03 Forbindelse, sammensetning og anvendelse ved behandling av koaguleringssykdommer

Country Status (18)

Country Link
US (1) US7285671B2 (no)
EP (1) EP1735296B1 (no)
JP (1) JP5036532B2 (no)
KR (1) KR101203124B1 (no)
AT (1) ATE451361T1 (no)
AU (1) AU2005233614C1 (no)
BR (1) BRPI0508392A (no)
CA (1) CA2559568C (no)
CY (1) CY1109763T1 (no)
DE (1) DE602005018181D1 (no)
DK (1) DK1735296T3 (no)
ES (2) ES2340690T3 (no)
HK (2) HK1105200A1 (no)
IL (1) IL178122A (no)
NO (1) NO338837B1 (no)
PT (1) PT1735296E (no)
RU (1) RU2495034C2 (no)
WO (1) WO2005100336A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60225434T2 (de) * 2001-04-24 2009-03-12 Aryx Therapeutics, Fremont Cumarin derivate und ihre verwendung als antikoagulantien
DK2161261T3 (da) * 2004-04-08 2013-11-04 Armetheon Inc Materialer og fremgangsmåder til behandling af koagulationslidelser
EP1954669B1 (en) * 2005-12-01 2015-07-08 Auspex Pharmaceuticals, Inc. Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity
CN101188435B (zh) * 2007-01-08 2011-03-16 中兴通讯股份有限公司 一种比特交织装置与方法
MX2010010504A (es) 2008-03-26 2010-12-15 Daiichi Sankyo Co Ltd Derivado de hidroxi-quinoxalin-carboxamida.
US20110136779A1 (en) * 2009-11-23 2011-06-09 Milner Peter G Methods for stroke reduction in atrial fibrillation patients
US9549912B2 (en) 2009-11-23 2017-01-24 Armetheon, Inc. Methods for treating atrial fibrillation
EP2521724B1 (en) * 2009-12-11 2016-11-23 Nono Inc. Agents and methods for treating ischemic and other diseases
JP5639665B2 (ja) 2010-02-12 2014-12-10 エヌサーティー・ファーマシューティカルズ・インコーポレーテッド Ｓ−ニトロソグルタチオンレダクターゼのクロモン阻害剤
AU2011215833B2 (en) 2010-02-12 2015-07-09 Nivalis Therapeutics, Inc. Novel S-nitrosoglutathione reductase inhibitors
US11234978B2 (en) 2014-01-15 2022-02-01 Southern Methodist University Inhibitors of multidrug resistance transporter P-glycoprotein
US10292982B2 (en) 2014-01-15 2019-05-21 Southern Methodist University Inhibitors of multidrug resistance transporter P-glycoprotein
US11013739B2 (en) 2014-01-15 2021-05-25 Southern Methodist University Inhibitors of multidrug resistance transporter p-glycoprotein
US9561227B2 (en) 2014-01-15 2017-02-07 Southern Methodist University Inhibitors of multidrug resistance transporter P-glycoprotein
CN114524791B (zh) * 2022-01-26 2024-01-26 江苏慧聚药业股份有限公司 替卡法林的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL108459A0 (en) 1993-02-05 1994-04-12 Opjohn Company 4-Hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl [B] pyran-2-ones useful for treating infections due to hiv and other retroviruses
US5510375A (en) 1993-11-19 1996-04-23 Warner-Lambert Company Coumarin derivatives as protease inhibitors and antiviral agents
GB9324517D0 (en) * 1993-11-30 1994-01-19 Octel Chem Ltd Process for the preparation of substituted 4-hydroxycoumarins
FR2749585B1 (fr) * 1996-06-11 1998-08-14 Hoechst Marion Roussel Inc Nouveaux derives aromatiques substitues par un ribose, leur procede de preparation et leur application comme medicaments
FR2807032B1 (fr) * 2000-03-29 2003-04-18 Warner Lambert Co Modification de la chimioselectivite lors de l'oxydation de composes organiques azotes
US7145020B2 (en) 2001-04-24 2006-12-05 Aryx Therapeutics Materials and methods for treating coagulation disorders
DE60225434T2 (de) * 2001-04-24 2009-03-12 Aryx Therapeutics, Fremont Cumarin derivate und ihre verwendung als antikoagulantien
EP1438297A1 (en) * 2001-10-10 2004-07-21 Aryx Therapeutics Mibefradil-based compounds as calcium channel blockers useful in the treatment of hypertension and angina
US7179838B2 (en) * 2002-07-30 2007-02-20 New Century Pharmaceuticals, Inc. Coumarin analog compounds for safer anticoagulant treatment

Also Published As

Publication number Publication date
EP1735296B1 (en) 2009-12-09
CA2559568C (en) 2013-05-28
RU2495034C2 (ru) 2013-10-10
NO338837B1 (no) 2016-10-24
US7285671B2 (en) 2007-10-23
AU2005233614A1 (en) 2005-10-27
DK1735296T3 (da) 2010-02-01
JP5036532B2 (ja) 2012-09-26
KR101203124B1 (ko) 2012-11-20
IL178122A0 (en) 2006-12-31
PT1735296E (pt) 2010-02-09
HK1105200A1 (en) 2008-02-06
RU2008120295A (ru) 2009-11-27
HK1138265A1 (en) 2010-08-20
EP1735296A1 (en) 2006-12-27
ATE451361T1 (de) 2009-12-15
AU2005233614C1 (en) 2012-07-19
JP2007532575A (ja) 2007-11-15
DE602005018181D1 (de) 2010-01-21
IL178122A (en) 2013-01-31
US20060287388A1 (en) 2006-12-21
WO2005100336A1 (en) 2005-10-27
CA2559568A1 (en) 2005-10-27
ES2340690T3 (es) 2010-06-08
CY1109763T1 (el) 2014-09-10
BRPI0508392A (pt) 2007-08-07
KR20060133081A (ko) 2006-12-22
AU2005233614B2 (en) 2011-11-24
ES2436298T3 (es) 2013-12-30

Similar Documents

Publication Publication Date Title
NO20065079L (no) Materialer og metoder for behandling av koaguleringssykdommer
NO20073140L (no) Pyrrolopyraziner og pyralopyraziner som er nyttige som inhibitorer av proteinkinaser
IS2696B (is) Setin 2-amínótetralín fyrir meðhöndlunina á geðdeyfð
NO20052595L (no) Sammensetninger anvendelige som inhibitorer av ROCK- og andre proteinkinaser.
NO20050851L (no) Kaspase-inhibitorer og anvendelser derav
NO20064976L (no) Azanidoler som er nyttige som inhibitorer av rock og andre proteinkinaser
NO20064325L (no) Heteroarylaminopyrazolderivativer nyttige for behandling av diabetes
NO20082026L (no) Deazapuriner som er nyttige som inhibitorer for Janus-kinaser
EA200501936A1 (ru) Производные пиридо[2,1-a]изохинолина в качестве ингибиторов dpp-iv
NO20082508L (no) Aminopyrimidiner anvendelige som kinaseinhibitorer
SE0403006D0 (sv) New compounds
EA200601802A1 (ru) Производные морфолина
NO20065847L (no) Difenylimidazopyrimidiner og -imidazolaminer som inhibitorer av B-sekretase
NO20055649L (no) Substituert dihydrokinazolin med antiviale egenskaper
EA200802329A1 (ru) Производные триазола ii
NO20072608L (no) Biaryloksymetylarenkarboksylsyrer
EA200802223A1 (ru) 1,5-дифенилпиразолы ii в качестве ингибиторов hsp90
NO20082096L (no) Azaindol-2-karboksamidderivativer
BR0309343A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
CY1108808T1 (el) Ενωσεις μοτιλιδης
NO20073830L (no) Medikamenter for behandling eller forebygging av fibrotiske sykdommer
ATE449776T1 (de) Pyrroloä2,3-cüpyridinderivate
ATE429916T1 (de) Verwendung von sulfonamid-derivaten bei der behandlung von adipositas oder zur verringerung der nahrungsaufnahme
UA86873C2 (en) SUBSTITUTED ARYL 1,4-PYRAZlNE DERIVATIVES
NO20061821L (no) Amidometylsubstituerte 1-(karboksyalkyl)-syklopentylkarbonylaminobenzazepin-N-eddiksyrederivater, fremgangsmate og mellomprodukter for deres fremstilling, og medikamenter som inneholder disse forbindelsene